Frontline Treatment of COPD
Definitions
COPD is an all-inclusive and nonspecific term that refers to a
defined set of breathing-related symptoms: chronic cough, expectoration,
varying degrees of exertional dyspnea, and a significant and progressive
reduction in expiratory airflow. Most patients with COPD are smokers.1
Airflow obstruction does not show major reversibility in response
to pharmacologic agents. Hyperinflation and a reduced diffusing
capacity may be present. Inflammatory damage to both airways (bronchitis),
and alveoli (emphysema), is found upon postmortem examination.
COPD is an umbrella term used to encompass several more specific
respiratory conditions that may exist individually or in any combination.
The terms chronic obstructive airways disease (COAD), chronic obstructive
lung disease (COLD), chronic airflow (or airways) obstruction (CAO),
and chronic airflow limitation (cal) all refer to the same disorder.
The specific components of COPD are as follows:
Chronic Obstructive Bronchitis
Chronic obstructive bronchitis can be found in patients with cough,
expectoration, and diminished airflow that does not improve significantly
after bronchodilator inhalation. Simple chronic bronchitis, or chronic
cough and expectoration with normal airflow, is not included in
this definition. Simple chronic bronchitis without airflow obstruction
has a good prognosis, and there is not such a severe social and
economic impact on patients, their families, or society. (Chronic
obstructive bronchitis is distinguished from asthmatic bronchitis,
discussed below, only by its lack of reversibility in response to
pharmacological agents.) Patients with pure chronic obstructive
bronchitis do not have physiologic or roentgenographic evidence
of hyperinflation. Diffusion tests are normal or nearly so.
Emphysema
Historically, emphysema was defined pathologically as reduced elastic
recoil and the disintegration of alveolar walls due to tissue breakdown
through the processes summarized in Section D. Clinically, emphysema
patients exhibit varying degrees of dyspnea upon exertion and irreversible
airflow obstruction. These patients also demonstrate abnormalities
at the air/blood interface that manifest in decreased carbon monoxide
uptake (measured by diffusion tests) and hyperinflation (judged
clinically by physical examination, x-ray, and measurements of total
lung capacity). Chronic bronchitis and emphysema, of course, usually
coexist because both are caused by tobacco smoking. Most clinicians
continue to use the term “COPD” for this reason.
Asthmatic Bronchitis
Patients with asthmatic bronchitis have pulmonary symptoms, including
productive cough, exertional dyspnea, and airflow obstruction, but
these symptoms and the obstruction reverse significantly in response
to inhaled beta-agonists, anticholinergics, methyl-xanthines, and
corticosteroids (used either alone or in combination). In these
patients, progressive airflow obstruction occurs over time and becomes
less reversible.
Diagnosing asthmatic bronchitis in its early stages, when airflow
abnormalities are just beginning to occur, may be profoundly important.
In both asthmatic and chronic bronchitis, bronchial hyperreactivity
probably results from airways inflammation caused by a variety of
irritants (including smoke). This hyperrespons-iveness is likely
to reverse significantly if the patient stops smoking, avoids other
irritants, and uses bronchodilators. The regular use of bronchodilators
or inhaled corticosteroids in the early stages of disease may help
forestall or prevent irreversible damage and may make impairment,
disability, and death from “endstage” COPD less likely.
In their later stages, chronic obstructive bronchitis and asthmatic
bronchitis may become indistinguishable. Therefore, airflow obstruction
that is chronic, progressive, and partially reversible in response
to bronchoactive drugs is the key indication of the bronchial component
of COPD.
References
Petty TL, Hodgkin JE. Definitions and epidemiology of COPD. Chapter
1 in Hodgkin JE, Petty TL (eds). Chronic Obstructive Pulmonary Disease:
Current Concepts. Philadelphia: WB Saunders, 1987. This chapter
presents useful clinical definitions for COPD.
1 The definition of COPD has
varied over the years. Today it includes ICD-9 codes for chronic
bronchitis (491), emphasema (492), and other chronic airways obstruction
(494-496). Isolated asthma, particularly reversible asthma (493),
is not included.
|